These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 16765793)

  • 1. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation.
    Donnenfeld ED; Solomon R; Roberts CW; Wittpenn JR; McDonald MB; Perry HD
    J Cataract Refract Surg; 2010 Jul; 36(7):1095-100. PubMed ID: 20610085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dry eye and regression after laser in situ keratomileusis for myopia.
    Albietz JM; Lenton LM; McLennan SG
    J Cataract Refract Surg; 2004 Mar; 30(3):675-84. PubMed ID: 15050267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine A for postoperative photorefractive keratectomy and laser in situ keratomileusis.
    Hessert D; Tanzer D; Brunstetter T; Kaupp S; Murdoch D; Mirzaoff M
    J Cataract Refract Surg; 2013 Apr; 39(4):539-47. PubMed ID: 23415779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN; Rao RD
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry eyes and corneal sensation after laser in situ keratomileusis with femtosecond laser flap creation Effect of hinge position, hinge angle, and flap thickness.
    Mian SI; Li AY; Dutta S; Musch DC; Shtein RM
    J Cataract Refract Surg; 2009 Dec; 35(12):2092-8. PubMed ID: 19969213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of visual results between laser-assisted subepithelial keratectomy and epipolis laser in situ keratomileusis to correct myopia and myopic astigmatism.
    Teus MA; de Benito-Llopis L; García-González M
    Am J Ophthalmol; 2008 Sep; 146(3):357-362. PubMed ID: 18614136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser in situ keratomileusis for refractive error after cataract surgery.
    Kim P; Briganti EM; Sutton GL; Lawless MA; Rogers CM; Hodge C
    J Cataract Refract Surg; 2005 May; 31(5):979-86. PubMed ID: 15975465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Epi-LASIK and off-flap Epi-LASIK for the treatment of low and moderate myopia.
    Kalyvianaki MI; Kymionis GD; Kounis GA; Panagopoulou SI; Grentzelos MA; Pallikaris IG
    Ophthalmology; 2008 Dec; 115(12):2174-80. PubMed ID: 19041475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
    Rao SN
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):603-9. PubMed ID: 21999340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femtosecond laser versus mechanical keratome LASIK for myopia.
    Montés-Micó R; Rodríguez-Galietero A; Alió JL
    Ophthalmology; 2007 Jan; 114(1):62-8. PubMed ID: 17070593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractive outcomes of laser in situ keratomileusis after flap complications.
    Sharma N; Ghate D; Agarwal T; Vajpayee RB
    J Cataract Refract Surg; 2005 Jul; 31(7):1334-7. PubMed ID: 16105603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser in situ keratomileusis versus lens-based surgery for correcting residual refractive error after cataract surgery.
    Jin GJ; Merkley KH; Crandall AS; Jones YJ
    J Cataract Refract Surg; 2008 Apr; 34(4):562-9. PubMed ID: 18361976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A control-matched comparison of laser epithelial keratomileusis and laser in situ keratomileusis for low to moderate myopia.
    Tobaigy FM; Ghanem RC; Sayegh RR; Hallak JA; Azar DT
    Am J Ophthalmol; 2006 Dec; 142(6):901-8. PubMed ID: 17157575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preoperative tear function on early functional visual acuity after laser in situ keratomileusis.
    Tanaka M; Takano Y; Dogru M; Toda I; Asano-Kato N; Komai-Hori Y; Tsubota K
    J Cataract Refract Surg; 2004 Nov; 30(11):2311-5. PubMed ID: 15519080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
    Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
    Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of laser in situ keratomileusis for myopia of up to -10 diopters.
    Alió JL; Muftuoglu O; Ortiz D; Pérez-Santonja JJ; Artola A; Ayala MJ; Garcia MJ; de Luna GC
    Am J Ophthalmol; 2008 Jan; 145(1):46-54. PubMed ID: 18154754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.